FBLG
FibroBiologics Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.31
-0.03 ▼ -8.14%
🌙 3월 13일 6:36 PM ET (한국 3/14 07:36)
$0.32
+0.00 +0.83%
| Index | - | P/E | - | EPS (ttm) | -0.44 | Insider Own | 15.74% | Shs Outstand | 0.07B | Perf Week | -28.18% |
| Market Cap | 0.02B | Forward P/E | - | EPS next Y | -7.45% | Insider Trans | 3.22% | Shs Float | 0.06B | Perf Month | 22.65% |
| Enterprise Value | 0.02B | PEG | - | EPS next Q | -0.07 | Inst Own | 6.96% | Short Float | 1.18% | Perf Quarter | -5.82% |
| Income | -0.02B | P/S | - | EPS this Y | 44.05% | Inst Trans | -3.23% | Short Ratio | 0.36 | Perf Half Y | -44.7% |
| Sales | 0.00B | P/B | 3.38 | EPS next 5Y | 11.36% | ROA | -89.89% | Short Interest | 0.67M | Perf YTD | 38.91% |
| Book/sh | 0.09 | P/C | 4.32 | EPS past 3/5Y | -38.37% -71.11% | ROE | -419.44% | 52W High | -79.58% ($1.53) | Perf Year | -69.07% |
| Cash/sh | 0.07 | P/FCF | - | Sales past 3/5Y | - | ROIC | -237.23% | 52W Low | 41.94% ($0.22) | Perf 3Y | - |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -30.2% | Gross Margin | - | Volatility(W/M) | 17.93% 14.59% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | - | Oper. Margin | - | ATR (14) | 0.05 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 3.61 | EPS Q/Q | 46.43% | Profit Margin | - | RSI (14) | 46.87 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 3.61 | Sales Q/Q | - | SMA20 | -3.54% ($0.32) | Beta | -0.87 | Target Price | $4.75 |
| Payout | - | Debt/Eq | 0.39 | Earnings | 2000000 | SMA50 | -0.31% ($0.31) | Rel Volume | 0.42 | Prev Close | $0.34 |
| Employees | 15 | LT Debt/Eq | 0.28 | EPS/Sales Surpr. | 35.42% - | SMA200 | -33.75% ($0.47) | Avg Volume(3M) | 1.86M | Price | $0.31 |
| IPO | 2024/1/31 | Option/Short | No/Yes | Trades | 1164 | Volume | 790,126 | Change | -8.14% |
뉴스 로딩 중...